Peter Mohr
- Oncology top 1%
- Cutaneous Melanoma Detection and Management 45
- CAR-T cell therapy research 35
- Cancer Immunotherapy and Biomarkers 31
- Immunology top 5%
- Immunotherapy and Immune Responses 20
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 32
- Dermatology top 2%
- Ophthalmology top 2%
-
- Nonmelanoma Skin Cancer Studies 10
-
- Cancer Genomics and Diagnostics 9
-
- Brain Metastases and Treatment 7
- Co-authors
- Dirk SchadendorfAxel HauschildClaus GarbeJochen UtikalPeter HerseyUwe TrefzerReinhard DummerJessica C. Hassel
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (18 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (11 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Peter Mohr
109 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.5k
- Immunology 705
- Molecular Biology 1.9k
- Dermatology 232
- Ophthalmology 215
Countries citing papers authored by Peter Mohr
This map shows the geographic impact of Peter Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mohr more than expected).
Fields of papers citing papers by Peter Mohr
This network shows the impact of papers produced by Peter Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mohr. The network helps show where Peter Mohr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 2 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 17 | |
| 16 | 2020 | 2 | |
| 17 | 2017 | 14 | |
| 18 | 2015 | 181 | |
| 19 | 2011 | 26 | |
| 20 | 2003 | 13 |
About Peter Mohr
Peter Mohr is a scholar working on Oncology, Dermatology, Immunology, Molecular Biology and Cancer Research, having authored 119 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (45 papers), CAR-T cell therapy research (35 papers), Melanoma and MAPK Pathways (32 papers), Cancer Immunotherapy and Biomarkers (31 papers), Immunotherapy and Immune Responses (20 papers), Nonmelanoma Skin Cancer Studies (10 papers), Cancer Genomics and Diagnostics (9 papers) and Brain Metastases and Treatment (7 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (705 citations), Molecular Biology (1.9k citations), Dermatology (232 citations) and Ophthalmology (215 citations). Peter Mohr has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dirk Schadendorf, Axel Hauschild, Claus Garbe, Jochen Utikal, Peter Hersey, Uwe Trefzer, Reinhard Dummer, Jessica C. Hassel, Caroline Robert and Piotr Rutkowski. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JDDG Journal der Deutschen Dermatologischen Gesellschaft, Melanoma Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.